Custo-efectividade de trastuzumab no tratamento de doentes com cancro da mama em estádios iniciais em Portugal.
Despite the important advances observed in the last 25 years in the comprehension of the clinical and biological nature of breast cancer and its treatment, this disease remains a significant cause of cancer morbidity and mortality worldwide. The clinical trial Hera has demonstrated the safety and ef...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Ordem dos Médicos
2010-06-01
|
| Edice: | Acta Médica Portuguesa |
| On-line přístup: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/631 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|